AP Pharma, Inc. (OTC:APPA) Threatens with Deeper Falls
The new trading week will start on a bad note for AP Pharma, Inc. (OTC:APPA) as it received depressing news from the FDA. Late on Thursday the stock ran down more than 36% to...
Tagged: TTNP
Titan Pharmaceuticals, Inc. (OTC:TTNP) Gets Out of Tangle, Shoots Up Again
After a series of jolts, Titan Pharmaceuticals, Inc. (OTC:TTNP) returns with a new promise, awaiting an FDA verdict on April 30th. The mix of positive and negative signals should keep this ticker high on...
Titan Pharmaceuticals, Inc. (OTC:TTNP) Gets Positive Vote, Approval Still Pending
The fortunes of Titan Pharmaceuticals, Inc. (OTC:TTNP) may turn, as the FDA reversed its stance on the latest addiction treatment proposed by the company. At the beginning of the week, the TTNP stock retreated...
RXI Pharmaceuticals, Corp. (OTC:RXII) Retreats After Two Days of Selling
As RXI Pharmaceuticals, Corp. (OTC:RXII) advances by leaps and bounds, it took one of its not unusual corrections, slumping down 18% on Wednesday’s trading. The company does not rely on a paid promotion, so...
Titan Pharmaceuticals, Inc. (OTC:TTNP) Crashes on FDA Refusal
When it comes to some penny stocks, no news is good news, and so was the case with Titan Pharmaceuticals, Inc. (OTC:TTNP) in the past few weeks. After a good start, this pharmaceutical stock...
RXi Pharmaceuticals, Corp. (OTC:RXII) Continues with Steep Climb
Biotechnologies continue to agitate the penny stock markets, and one of the more robust climbers in March is Rxi Pharmaceuticals, Corp. (OTC:RXII), another explorer of novel therapies using RNA to cure disease by switching...
Amarantus Bioscience, Inc. (OTC:AMBS) Reports Positive Trial Results
We have been waiting for a couple of weeks for Amarantus Bioscience, Inc. (OTC:AMBS) to choose a direction, and while the ticker has been stagnant for a while, the company is pointing to developments...
Quality Stocks Promotion Still Affects Advaxis, Inc. (OTC:ADXS)
Bio-pharmaceutical companies often offer a steep climb to investor Heaven. Like several other biotech tickers, 2013 started with a healthy growth for Advaxis, Inc. (OTC:ADXS). The ticker added more than 24% yesterday for one...
Titan Pharmaceutical, Inc. (OTC:TTNP) Attracts Investors on Nearing FDA Verdict
Pharmaceutical companies run on a make it or break it regime, and Titan Pharmaceuticals, Inc. (OTC:TTNP) seems to be making it, charting a steep upward move of its stock. The buying volumes are near...